No Data
No Data
NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
NeuroOne Announces First Implant of OneRF Ablation Electrodes
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024
NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surg
NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited commercial launch
NeuroOne Medical Advances With Key Shareholder Decisions